-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
- Akero Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$81.7M, a 75.3% decline year-over-year.
- Akero Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$269M, a 97.4% decline year-over-year.
- Akero Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$173M, a 50.1% decline from 2022.
- Akero Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$115M, a 14.1% decline from 2021.
- Akero Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$101M, a 25.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)